Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection
Recruiting now · Not applicable
Conditions studied: Lung Cancer, Surgery
In brief
The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.
Key facts
- Study ID
- NCT06531460
- Run by
- National Institute of Respiratory Diseases, Mexico
- People needed
- 310
- Starts
- 2024-07-25
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2024-08-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Lung cancer diagnosis
- Elective surgery for lung resection schedule at least four days before surgery
- Signed informed consent.
You may not qualify if…
- Acute or chronic organ failure as hepatic or renal insufficiency
- Patients with fish-allergy
- History of any surgery within 3 months
- Immunocompromised patients
Where it is running
- National Institute of Respiratory Diseases — Mexico City, Mexico (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.